tiprankstipranks
Trending News
More News >
Strata Critical Medical (SRTA)
NASDAQ:SRTA
US Market
Advertisement

Strata Critical Medical (SRTA) Earnings Dates, Call Summary & Reports

Compare
1,007 Followers

Earnings Data

Report Date
Mar 17, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.04
Last Year’s EPS
-0.13
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 10, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, successful strategic transactions, and strong profit margins, setting a positive outlook for future cash flow generation. However, challenges such as the impact of the Joby transaction stock price and ongoing legal issues were noted.
Company Guidance
During the Strata Critical Medical fiscal third-quarter 2025 earnings call, the company provided robust guidance, highlighting a significant year-over-year revenue growth of 29%, excluding the recent Keystone acquisition. The company reported an all-time high in segment adjusted EBITDA performance, with an 80% increase year-over-year, also excluding Keystone. The medical segment adjusted EBITDA margin improved to over 15% in Q3 2025, compared to 10.8% in the previous year and 12.5% in the first half of the year. Despite a seasonal sequential decline in industry-wide transplant volumes by approximately 6%, Strata's revenue rose 3% sequentially. The company also raised its 2025 revenue guidance to $185-$195 million and reaffirmed its adjusted EBITDA guidance range of $13-$14 million. Additionally, Strata expects medical segment adjusted EBITDA margins to increase in Q4 2025 driven by the Keystone acquisition.
Revenue Growth and Profitability
Year-over-year revenue growth accelerated to 29% excluding Keystone, with record segment adjusted EBITDA performance seeing 80% growth. Medical segment adjusted EBITDA margin increased to over 15% in Q3 2025, up from 10.8% in the prior year.
Strategic Transactions and Rebranding
Completed two transformational transactions: divestiture of the passenger business and acquisition of Keystone Perfusion. Rebranded as Strata Critical Medical with a new ticker symbol, SRTA.
Positive Free Cash Flow
Generated positive free cash flow from continuing operations, with expectations to consistently generate free cash flow moving forward.
Strong Performance in New and Existing Services
Revenue from organ placement services more than doubled year-over-year, and a new organ logistics customer was added late in Q3.

Strata Critical Medical (SRTA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SRTA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 17, 2026
2025 (Q4)
0.04 / -
-0.127
Nov 10, 2025
2025 (Q3)
0.02 / -0.12
-0.03-300.00% (-0.09)
Aug 05, 2025
2025 (Q2)
-0.04 / -0.05
-0.1566.67% (+0.10)
May 12, 2025
2025 (Q1)
-0.12 / -0.04
-0.0633.33% (+0.02)
Mar 13, 2025
2024 (Q4)
-0.12 / -0.13
-0.4571.78% (+0.32)
Nov 12, 2024
2024 (Q3)
-0.02 / -0.03
0
Aug 07, 2024
2024 (Q2)
-0.03 / -0.15
-0.1711.76% (+0.02)
May 07, 2024
2024 (Q1)
-0.10 / -0.06
-0.1457.14% (+0.08)
Mar 12, 2024
2023 (Q4)
-0.12 / -0.45
-0.22-104.55% (-0.23)
Nov 08, 2023
2023 (Q3)
-0.07 / 0.00
-0.129
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SRTA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 10, 2025
$4.43$4.85+9.48%
Aug 05, 2025
$4.43$4.16-6.09%
May 12, 2025
$2.92$3.46+18.49%
Mar 13, 2025
$2.83$3.03+7.07%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Strata Critical Medical (SRTA) report earnings?
Strata Critical Medical (SRTA) is schdueled to report earning on Mar 17, 2026, After Close (Confirmed).
    What is Strata Critical Medical (SRTA) earnings time?
    Strata Critical Medical (SRTA) earnings time is at Mar 17, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SRTA EPS forecast?
          SRTA EPS forecast for the fiscal quarter 2025 (Q4) is 0.04.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis